Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
/in Hyperthermia, International Publications, Prostate Cancer /von Mark Hurwitz, Gregory T Martin, Daniel A Sidney, Charles J Welch, Jorgen L Hansen, Bruce A Bornstein, Irving D. Kaplan, H F Bowman; Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA; MIT, Cambridge, MA; Hemedex, Cambridge, MA; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MAThe effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial
/in Cervical Cancer, Hyperthermia, International Publications /von Minnaar CA, Kotzen JA, Ayeni OA, Naidoo T, Tunmer M, Sharma V, Vangu MD, Baeyens AModulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro
/in Colorectal Cancer, Hyperthermia, International Publications /von Vancsik T, Forika G, Balogh A, Kiss E, Krenacs TA phase I trial evaluating the safety and efficacy of weekly paclitaxel or cisplatin with electro-hyperthermia in patients with recurrent or persistent epithelial ovarian, fallopian tubal or primary peritoneal carcinoma (KGOG 3030).
/in Hyperthermia, International Publications, Ovarian Cancer /von Kidong Kim, Dong-Hoon Suh, Jae Hong No, Yong Beom Kim, Jae Hoon Kim, Seung Cheol Kim, Woong Ju, Yun Hwan Kim; Korea Cancer Center Hospital, Seoul, South Korea; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Si, South Korea; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Si, South Korea; Yonsei University College of Medicine, Seoul, South Korea; Department of Obstetrics and Gynecology, Ewha Woman's University Mokdong Hospital, Ewha Woman's University School of Medicine, Seoul, South Korea; Ewha Womans University, Seoul, South Korea; Ewha Womans University College of Medicine, Seoul, South KoreaPhase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer
/in Hyperthermia, International Publications, Ovarian Cancer /von Yoo HJ, Lim MC, Seo SS, Kang S, Joo J, Park SYWhole-body hyperthermia in combination with systemic therapy in advanced solid malignancies
/in Hyperthermia, International Publications /von Lassche G, Crezee J, Van Herpen CMLRadiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
/in Hyperthermia, International Publications, NSCLC /von Yang WH, Xie J, Lai ZY, Yang MD, Zhang GH, Li Y, Mu JB, Xu JNew physical approaches to treat cancer stem cells: a review
/in Hyperthermia, International Publications /von Ghaffari H, Beik J, Talebi A, Mahdavi SR, Abdollahi HMild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice
/in Hyperthermia, International Publications /von Cohen J, Anvari A, Samanta S, Poirier Y, Soman S, Alexander A, Ranjbar M, Pavlovic R, Zodda A, Jackson IL, Mahmood J, Vujaskovic Z, Sawant A
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.
- Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
- Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).